Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD).

[1]  N. Kawasaki,et al.  Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions. , 2012, Pharmacology & therapeutics.

[2]  I. Hirano,et al.  Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. , 2012, Gastroenterology.

[3]  A. Schoepfer,et al.  Pediatric and adult eosinophilic esophagitis: similarities and differences , 2012, Allergy.

[4]  S. Specht,et al.  Granulocytes in Helminth Infection - Who is Calling the Shots? , 2012, Current medicinal chemistry.

[5]  Torsten Haferlach,et al.  Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field , 2012, Expert review of hematology.

[6]  R. Sindwani.  Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis , 2012 .

[7]  M. Tourigny,et al.  Changes in thymic regulatory T-cell maturation from birth to puberty: differences in atopic children. , 2012, The Journal of allergy and clinical immunology.

[8]  S. K. Frankel,et al.  Eosinophilic Lung Diseases , 2011, The Medical clinics of North America.

[9]  James J. Lee,et al.  Update on clinical and immunological features of eosinophilic gastrointestinal diseases , 2011, Current opinion in gastroenterology.

[10]  E. King,et al.  Long-term outcomes in pediatric-onset esophageal eosinophilia. , 2011, The Journal of allergy and clinical immunology.

[11]  A. Schoepfer,et al.  Eosinophilic esophagitis: updated consensus recommendations for children and adults. , 2011, The Journal of allergy and clinical immunology.

[12]  R. Locksley,et al.  Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis , 2011, Science.

[13]  C. Berek,et al.  Eosinophils are required for the maintenance of plasma cells in the bone marrow , 2011, Nature Immunology.

[14]  E. King,et al.  Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999. , 2010, The Journal of allergy and clinical immunology.

[15]  A. Wardlaw,et al.  Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. , 2010, The Journal of allergy and clinical immunology.

[16]  K. Stringer,et al.  Involvement of mast cells in eosinophilic esophagitis. , 2010, The Journal of allergy and clinical immunology.

[17]  G. Gleich,et al.  What targeting eosinophils has taught us about their role in diseases. , 2010, The Journal of allergy and clinical immunology.

[18]  H. Simon,et al.  Refining the definition of hypereosinophilic syndrome. , 2010, The Journal of allergy and clinical immunology.

[19]  E. Israel,et al.  Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome. , 2010, The Journal of allergy and clinical immunology.

[20]  James J. Lee,et al.  Eosinophils in health and disease: the LIAR hypothesis , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  W. Bergfeld,et al.  Quantitative Analysis of Eosinophils in Acute Graft-Versus-Host Disease Compared With Drug Hypersensitivity Reactions , 2010, The American Journal of dermatopathology.

[22]  J. Sheikh,et al.  Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. , 2009, The Journal of allergy and clinical immunology.

[23]  P. Sly,et al.  Thymic indoleamine 2,3-dioxygenase-positive eosinophils in young children: potential role in maturation of the naive immune system. , 2009, The American journal of pathology.

[24]  J. Cools,et al.  Recent breakthroughs in the understanding and management of chronic eosinophilic leukemia , 2009, Expert review of anticancer therapy.

[25]  J. Butterfield.  Success of short-term, higher-dose imatinib mesylate to induce clinical response in FIP1L1-PDGFRalpha-negative hypereosinophilic syndrome. , 2009, Leukemia research.

[26]  P. Weller,et al.  Immunoregulatory roles of eosinophils: a new look at a familiar cell , 2008, Clinical and Experimental Allergy.

[27]  James J. Lee,et al.  Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. , 2008, Human molecular genetics.

[28]  J. Parkin,et al.  Treatment of patients with the hypereosinophilic syndrome with mepolizumab. , 2008, The New England journal of medicine.

[29]  C. Derk,et al.  Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature , 2007, International journal of dermatology.

[30]  A. Straumann,et al.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. , 2007, Gastroenterology.

[31]  S. Ackerman,et al.  Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders. , 2007, Immunology and allergy clinics of North America.

[32]  M. Wechsler.  Pulmonary eosinophilic syndromes. , 2007, Immunology and allergy clinics of North America.

[33]  H. Rosenberg.  Faculty Opinions recommendation of Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. , 2007 .

[34]  Marc E. Rothenberg,et al.  Regulation of Carcinogenesis by IL-5 and CCL11: A Potential Role for Eosinophils in Tumor Immune Surveillance1 , 2007, The Journal of Immunology.

[35]  M. Rothenberg,et al.  Eosinophilic esophagitis: pathogenesis, genetics, and therapy. , 2006, The Journal of allergy and clinical immunology.

[36]  M. Peters,et al.  Reflections on eosinophils and flame figures: where there's smoke there's not necessarily Wells syndrome. , 2006, Archives of dermatology.

[37]  P. Itin,et al.  Eosinophilic Fasciitis 30 Years after – What Do We Really Know? , 2006, Dermatology.

[38]  J. Cordier,et al.  Idiopathic chronic eosinophilic pneumonia. , 2006, Seminars in respiratory and critical care medicine.

[39]  K. G. Effat.  Angiolymphoid hyperplasia with eosinophilia of the auricle: progression of histopathological changes , 2006, The Journal of Laryngology & Otology.

[40]  B. Aronow,et al.  Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. , 2006, The Journal of clinical investigation.

[41]  R. Noel,et al.  Eosinophilic esophagitis , 2005, Current opinion in pediatrics.

[42]  A. Ghahary,et al.  Cutting Edge: Human Eosinophils Regulate T Cell Subset Selection through Indoleamine 2,3-Dioxygenase1 , 2004, The Journal of Immunology.

[43]  S. Orkin,et al.  A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.

[44]  E. Lenkiewicz,et al.  Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.

[45]  L. Thompson,et al.  Kimura Disease: A Clinicopathologic Study of 21 Cases , 2004, The American journal of surgical pathology.

[46]  S. Ehlers,et al.  Update on the pathogenesis of Churg-Strauss syndrome. , 2003, Clinical and experimental rheumatology.

[47]  Peter Marynen,et al.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. , 2003, The New England journal of medicine.

[48]  I. Noth,et al.  Churg-Strauss syndrome , 2003, The Lancet.

[49]  P. Foster,et al.  Experimental analysis of eosinophil-associated gastrointestinal diseases , 2002, Current opinion in allergy and clinical immunology.

[50]  D. Abramowicz,et al.  A role for eosinophils in transplant rejection. , 2001, Trends in immunology.

[51]  James J. Lee,et al.  Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. , 1999, The Journal of clinical investigation.

[52]  L. Guillevin,et al.  Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. , 1999, Medicine.

[53]  D. Friend,et al.  Eotaxin is required for the baseline level of tissue eosinophils. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Silver,et al.  Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. , 1992, Blood.

[55]  G. Gleich,et al.  Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. , 1990, The New England journal of medicine.

[56]  H. Pehamberger,et al.  Episodic angioedema with eosinophilia. , 1989, Journal of the American Academy of Dermatology.

[57]  C. Michet,et al.  Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. , 1988, Seminars in arthritis and rheumatism.

[58]  G. Gleich,et al.  Episodic angioedema associated with eosinophilia. , 1984, The New England journal of medicine.